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The replicase of Semliki Forest virus (SFV) consists of four non-structural proteins, designated
nsP1–4, and is bound to cellular membranes via an amphipathic peptide and palmitoylated
cysteine residues of nsP1. It was found that mutations preventing nsP1 palmitoylation also
attenuated virus replication. The replacement of these cysteines by alanines, or their deletion,
abolished virus viability, possibly due to disruption of interactions between nsP1 and nsP4, which
is the catalytic subunit of the replicase. However, during a single infection cycle, the ability of the
virus to replicate was restored due to accumulation of second-site mutations in nsP1. These
mutations led to the restoration of nsP1–nsP4 interaction, but did not restore the palmitoylation of
nsP1. The proteins with palmitoylation-site mutations, as well as those harbouring compensatory
mutations in addition to palmitoylation-site mutations, were enzymically active and localized, at
least in part, on the plasma membrane of transfected cells. Interestingly, deletion of 7 aa including
the palmitoylation site of nsP1 had a relatively mild effect on virus viability and no significant
impact on nsP1–nsP4 interaction. Similarly, the change of cysteine to alanine at the palmitoylation
site of nsP1 of Sindbis virus had only a mild effect on virus replication. Taken together, these
findings indicate that nsP1 palmitoylation as such is not the factor determining the ability to bind to
cellular membranes and form a functional replicase complex. Instead, these abilities may be linked
to the three-dimensional structure of nsP1 and the capability of nsP1 to interact with other
components of the viral replicase complex.
INTRODUCTION
The alphaviruses (family Togaviridae) are enveloped,
positive-strand RNA viruses that infect both vertebrate
hosts and insect vectors (Strauss & Strauss, 1994). Due to
their broad host range, high levels of protein expression
and small genomes, alphaviruses have been extensively
exploited as models. Semliki Forest virus (SFV) is one of
the best-studied alphaviruses. The SFV genome is approxi-
mately 11.5 kb long and has a 59 cap structure and 39
poly(A) sequence. It encodes four non-structural proteins
(nsP1–4), involved in viral RNA synthesis, and five
structural proteins. After virus entry into the cell, the
genomic RNA is translated into a large, non-structural
polyprotein, which is processed to form an early and
subsequently a late replicase complex (Strauss & Strauss,
1994). The early replicase complex mediates synthesis of
the negative-strand RNA, which, in turn, is used by the late
replicase complex as template for synthesis of new genomes
and subgenomic RNA for structural proteins. Structural
genes are not required for replication and thus can be
replaced with a polylinker and/or with foreign sequences in
order to obtain SFV-based replicon vectors (Liljestrom &
Garoff, 1991).
The nsP1 protein is required for alphavirus RNA replica-
tion. It has been shown that nsP1 is required for synthesis
of negative-strand RNAs (Wang et al., 1991) and that nsP1
catalyses the capping reaction of viral RNAs (Ahola &
Kaariainen, 1995; Wang et al., 1996). It is also the only
non-structural protein to interact with membranes (Ahola
et al., 1999; Salonen et al., 2003). The membrane
association of nsP1 is mediated through direct interaction
of the amphipathic binding peptide (BP) with anionic
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translational palmitoylation of between one and three
cysteine residues at positions 418–420 (Laakkonen et al.,
1996). It has recently been demonstrated that nsP1 can
only become palmitoylated after associating with mem-
branes via the BP (Spuul et al., 2007). The replacement of
cysteines at the palmitoylation site with alanines abolishes
palmitoylation of nsP1 completely, whereas the essential
enzymic activities of the protein, as well as its ability to
bind to cellular membranes, are not destroyed (Laakkonen
et al., 1996). It has also been reported that the cysteine-to-
alanine mutations did not have a significant effect on SFV
viability or growth in cell culture, although SFV1PA2 virus
was avirulent in mice (Ahola et al., 2000).
Here, we demonstrate that substitutions or deletions at the
nsP1 palmitoylation site and its surrounding sequences
seriously affect the viability of SFV. The subsequent
replication of the mutant viruses to high titres was found
to be due to the accumulation of second-site compensatory
mutations, which restored the interaction between nsP1
and nsP4 that was abolished by the primary mutations at
the palmitoylation site.
METHODS
Cells, virus strains and media. BHK-21 cells were grown in
Glasgow’s minimal essential medium (GMEM) containing 5% fetal
calf serum (FCS), 10% tryptose phosphate broth, 100 U penicillin
ml
21 and 0.1 mg streptomycin ml
21. Cos-7 cells were grown in
Iscove’s modified Dulbecco’s medium containing 10% FCS, 100 U
penicillin ml
21 and 0.1 mg streptomycin ml
21. HeLa cells were grown
in Dulbecco’s modified Eagle’s medium containing 10% FCS, 2 mM
glutamine, 100 U penicillin ml
21 and 0.1 mg streptomycin ml
21. The
SFV4 strain was derived from the infectious cDNA (icDNA) clone
pSP6-SFV4 (Liljestrom & Garoff, 1991), and wild-type (wt) Sindbis
virus (SIN) from the clone pTOTO1101 (Rice et al., 1987). A
derivative of SIN with replacement of cysteine at the palmitoylation
site by alanine was derived from plasmid pSIN1PA2 (Ahola et al.,
2000). Modified recombinant vaccinia virus Ankara expressing T7
RNA polymerase (MVA-T7) was kindly provided by Bernard Moss
(NIH, Bethesda, MD, USA).
Construction of SFV mutants. Replacement of the three cysteine
residues at positions 418–420 with alanines (hereafter designated
mut3A) and deletion of the three cysteine residues at positions 418–
420, designated D3, or of the RSLTCCC sequence at positions 414–
420, designated D7, were performed by PCR-based mutagenesis. PCR
was performed on the pTSF1 template (Peranen et al., 1993) and the
DNA fragments with introduced mutations were cloned into a
derivative of pSFV1 (Liljestrom & Garoff, 1991), pSFV1/d1EGFP, by
exchange of the Pfl23II–SacI fragment to obtain pSFV1mut3A/
d1EGFP, pSFV1D3/d1EGFP and pSFV1D7/d1EGFP. Plasmids con-
taining full-length icDNA (pSFV4mut3A, pSFV4D3 and pSFV4D7)
were created by subsequent replacement of XbaI–SpeI fragments in
the corresponding replicon plasmids by structural genes from
pHelper1 (Liljestrom & Garoff, 1991). The replicons and genomes
with identified compensatory mutations were obtained by similar
cloning procedures.
Construction of plasmids for transient expression. The regions
encoding nsP2 and nsP3 were excised from pTSF2 and pTSF3, res-
pectively (Peranen, 1991), with appropriate restriction endonucleases.
The coding sequence of SFV4 nsP4 was PCR amplified using pSP6-
SFV4 as the template and primers containing appropriate restriction
endonucleasesites.Fragmentswereclonedinto pCG3F12inframe with
a bovine papillomavirus type 1 E2 protein-derived 3F12 epitope tag
(Kaldalu et al., 2000). The coding sequence of nsP1 was cloned into the
same expression vector without the 3F12 tag. The resulting constructs
were designated pCGnsP1, pCG3F12nsP2, pCG3F12nsP3 and
pCG3F12nsP4. The mut3A, D3 and D7 mutations were introduced
into pCGnsP1 by subcloning and the resulting plasmids were
designated pCGmut3A, pCGD3 and pCGD7. Compensatory muta-
tions, together with mut3A and D3 mutations, were subcloned into the
pCGmut3A and pCGD3 vectors by the use of the unique restriction
sites within the nsP1 sequence and the resulting clones were designated
pCGmut3A/P181Q, pCGmut3A/L234F, pCGmut3A/Q357L, pCGD3/
M124V+A197D and pCGD3/DG224+T352S.
For expression of nsP1 mutant variants in HeLa cells, the pTSF1
vector (Peranen et al., 1993) was used. The mutations mut3A, D3 and
D7, alone or together with corresponding compensatory mutations,
were subcloned into pTSF1 from corresponding pCG vectors with
EcoRV and MluI endonucleases. The resulting constructs were
designated pTSFmut3A, pTSFD3, pTSFD7, pTSFmut3A/P181Q,
pTSFmut3A/L234F, pTSFmut3A/Q357L, pTSFD3/M124V+A197D
and pTSFD3/DG224+T352S.
Construction of plasmids for bacterial expression. The pBAT1
expression vector was used for expression of derivatives of nsP1 in
Escherichia coli (Ahola et al., 1997). The nsP1 sequences carrying
mut3A, D3 and D7, alone or together with compensatory mutations,
were transferred to pBAT1 from the corresponding pTSF1 vectors by
NcoI–HindIII fragment exchange. The resulting clones were desig-
nated pBATmut3A, pBATD3, pBATD7, pBATmut3A/P181Q,
pBATmut3A/L234F, pBATmut3A/Q357L, pBATD3/M124V+A197D
and pBATD3/DG224+T352S.
RNA transcription and transfection. SFV-based replicons and
icDNA plasmids were linearized by SpeI digestion; pTOTO1101 based
plasmids were linearized by XhoI digestion. RNAs were synthesized by
SP6 RNA polymerase and used for cell transfection by electroporation
as described previously (Karlsson & Liljestrom, 2003). Primary virus
stocks were collected from transfected cell cultures after incubation at
37 uC for 24 h.
Virological methods. Confluent monolayers of BHK-21 cell culture
were washed with PBS, infected at an m.o.i. of 10 for 1 h at 37 uC and
overlaid with complete medium. BHK-21 cells (8610
6 cells) were
transfected with 50 mg in vitro-synthesized RNA or infected at an
m.o.i. of 10 as described above. At selected time points, 150 ml
medium was sampled and virus titres in the harvested samples were
determined by plaque assay.
For the infectious centre assay, 1 mg in vitro-synthesized RNA was
used for electroporation of 8610
6 BHK-21 cells. When needed, the
amount of RNA transcripts used was increased to 10 mg. Tenfold
dilutions of electroporated cells were seeded in six-well tissue-culture
plates containing 1.5610
6 BHK-21 cells per well. After 2 h incubation
at 37 uC, cells were overlaid with 2 ml carboxymethylcellulose (CMC)
containing GMEM (2% CMC : GMEM ratio 2 : 3, final concentra-
tion FCS 1.2%). Plaques were stained with crystal violet after 2 days
incubation at 37 uC.
For isolation of pseudorevertant viruses, 100 mm dishes of confluent
BHK-21 cells were infected with primary stocks of the mutant viruses
to obtain 20–50 plaques per plate. After 1 h incubation at 37 uC, cells
were overlaid with 5 ml 0.9% (w/v) agarose solution in GMEM and
incubated for a further 2 days at 37 uC. To visualize plaques, the plates
were overlaid with 3 ml 0.9% (w/v) agarose/water solution contain-
ing 1% (w/v) neutral red, and incubated overnight at 37 uC. Visible
E. Z ˇusinaite and others
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GMEM. Stocks of viral clones were further amplified in BHK-21 cells.
Mapping of compensatory mutations. Viral RNA was purified by
using the NucleoSpin RNA II system (Macherey-Nagel) and used for
reverse transcription by RevertAid M-MuLV reverse transcriptase
(Fermentas). The non-structural region of the SFV genome was PCR-
amplified using a set of 13 pairs of primers and sequenced.
Amplification and sequencing were repeated for fragments containing
identified mutations.
Co-immunoprecipitation. Plasmids containing native or mutant
sequences of SFV nsP1 were electroporated pairwise with plasmids
pCG3F12nsP2, pCG3F12nsP3, or pCG3F12nsP4 (3 mg of each
plasmid) into Cos-7 cells. Forty-eight hours post-transfection, the
transfected cells were lysed in RIPA lysis buffer [50 mM Tris (pH 7.5),
400 mM NaCl, 1 mM EDTA, 1% Igepal CA-630 (Sigma), 1% sodium
deoxycholate, 0.1% SDS, 1 mM PMSF and EDTA-free protease
inhibitor cocktail (Roche)] for 20 min on ice, incubated at 280 uC for
30 min and thawed on ice. The non-lysed fraction was removed by
centrifugation at 15 000 g for 20 min. Protein concentration in
cleared cell lysates was measured by Bradford assay. The amount of
lysate corresponding to 1 mg total protein was incubated with nsP1-
specific rabbit polyclonal antibody overnight at 4 uC. The immune
complexes were precipitated with protein A–Sepharose CL-4B
(Amersham Biosciences), pre-equilibrated in TNE buffer [50 mM
Tris (pH 7.5), 400 mM NaCl, 1 mM EDTA]. Sepharose beads were
washed four times with TNE buffer and precipitated proteins were
denatured by boiling for 5 min in 50 ml Laemmli buffer. The amount
of sample corresponding to 250 mg total protein was subjected to
SDS-PAGE (12% gel). Proteins were transferred to a nitrocellulose
membrane, probed with the mouse 3F12 tag-specific monoclonal
antibody (Kaldalu et al., 2000) and visualized by using the ECL system
(Amersham Biosciences).
Immunofluorescence microscopy and palmitoylation assay.
Indirect immunofluorescence microscopy of transfected cells was
carried out essentially as described by Salonen et al. (2003).
Palmitoylation assay of the transiently expressed proteins was carried
out as described by Spuul et al. (2007).
Expression of recombinant proteins in E. coli and guanylyl-
transferase (GT) assay. E. coli strain BL21 (DE3) was transformed
with the expression plasmid pBAT1 containing wt or mutant nsP1
sequences. Conditions for cell growth and recombinant protein
expression have been described elsewhere (Laakkonen et al., 1994).
Cells from 50 ml bacterial culture were collected at 4000 g for 10 min,
resuspended in 1 ml lysis buffer [50 mM Tris/HCl (pH 8.0), 50 mM
NaCl, 20% glycerol, 0.1% Tween 20, 1 mM DTT, 1 mM PMSF] and
sonicated. The lysate was cleared by centrifugation at 15 000 g for
20 min at 4 uC, and the resulting supernatant (S15 fraction) was used
for GT reaction or Western blotting. The covalent guanylyl complex
formation reaction was carried out for 20 min at 30 uC in a mixture
(total volume 30 ml) that contained 5 mCi (185 MBq) [a-
32P]GTP
(400 Ci mmol
21) in 50 mM Tris/HCl (pH 7.5), 10 mM KCl, 2 mM
MgCl2, 5 mM DTT, 100 mM AdoMet (Sigma) and 5 ml sample (Ahola
& Kaariainen, 1995).
RESULTS
Mutations at the nsP1 palmitoylation site affect
SFV viability
Three SFV-based replicons, containing mutations at the
palmitoylation site and expressing d1EGFP as a marker,
were constructed and analysed (Fig. 1). Transfection of
BHK-21 cells revealed that ,1% of cells transfected with
Fig. 1. Schematic presentation and infectivity of SFV-based replicons and genomes with mutations at the palmitoylation site of
nsP1. The infectivity of SFV-based replicons was measured as a percentage of EGFP-positive cells in 810
6 BHK-21 cells
transfected with 50 mg RNA. The mean±SD of three experiments are shown. Infectivity of full-length SFV genomes was
measured by infectious centre assay; the experiment was repeated twice with similar results.
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d1EGFP-positive, whereas transfection with SFV1D7/
d1EGFP RNA resulted in approximately 40% of cells
expressing d1EGFP. Under the same conditions, the
percentage of d1EGFP-positive cells was .90% in cultures
transfected with SFV1/d1EGFP. This severe effect of
mutations at the palmitoylation site on the replication
ability and marker gene expression of SFV-based replicons
was unexpected, as similar changes in the context of the
full-length SFV genome have previously been reported not
to have a serious influence on SFV viability (Ahola et al.,
2000). To clarify the situation, all three mutations were
transferred into pSP6-SFV4 and the infectivity of the
corresponding RNA transcripts was analysed by infectious
centre assay. It was found that the infectivity of
SFV4mut3A and SFV4D3 RNAs was four orders of
magnitude lower than that of SFV4 RNA, whereas the
RNA infectivity of SFV4D7 was reduced by only about 40-
fold (Fig. 1). Thus, both mut3A and D3 dramatically
reduced infectivity of the corresponding transcripts, with
D7 having a milder effect.
Infectivity of the mutated SFV is restored during a
single passage in cell culture
The most likely explanation for the seeming discrepancy
between the effect of mut3A on virus replication described
above and by Ahola et al. (2000) is the accumulation of
changes with a positive impact on virus replication during
virus propagation. To verify this hypothesis, we compared
the release of viruses from transfected BHK-21 cells with
that from BHK-21 cells infected with the corresponding
viruses. It was found that the growth of the SFV4mut3A,
SFV4D3 and SFV4D7 in transfected cells was delayed
significantly compared with that of SFV4 (Fig. 2a). The
release of infectious virions was detected at 4 h post-
transfection for SFV4; in contrast, the titres of the mutant
viruses were below detection limits up to 6–8 h post-
transfection. Consistent with previous findings, SFV4D7
showed the quickest growth among the mutants. The titres
of SFV4 reached their maximum (10
9 p.f.u. ml
21)1 0h
post-transfection, whereas the titres of mutated viruses
were always lower and continued to grow even at 24 h
post-transfection (Fig. 2a). When BHK-21 cell cultures
were infected with the primary stocks of SFV4,
SFV4mut3A, SFV4D3 or SFV4D7, no significant difference
between the growth curves of these viruses was detected
(Fig. 2b). Thus, our results support the hypothesis that
some changes took place during propagation of these
mutant viruses.
Mutation of the nsP1 palmitoylation site has a
mild effect on SIN viability and replication
In order to study the effect in another alphavirus, the
infectious centre assay was also performed with transcripts
originating from pTOTO1101 and pSIN1PA2, the mutant
construct where the only cysteine residue at the nsP1
palmitoylation site is substituted with alanine (Ahola et al.,
2000). It was found that the mutation at the palmitoylation
site reduced the infectivity of SIN transcripts by only about
30-fold. In growth-curve experiments, the release of
infectious virions from cells transfected with transcripts
from pTOTO1101 or pSIN1PA2 was, in both cases, detected
at 4 h post-transfection, and only a small (,1 log)
reduction in the titre of SIN1PA2, compared with that of
SIN, was observed between 4 and 10 h post-transfection; at
later time points, no statistically significant difference
between titres of these viruses was observed (data not
shown). These results are consistent with the previous
report that the mutation at the palmitoylation site of nsP1
has only a minor effect on the viability and replication of
SIN (Ahola et al., 2000) and, accordingly, no compensatory
changes are required to restore the replication of the
mutant SIN genome.
Identification of putative compensatory mutations
in SFV
RT-PCR and sequencing analysis confirmed the presence of
original mutations at the palmitoylation site of nsP1 for all
three recombinant SFV stocks. To identify the possible
second-site compensatory mutations, four isolates for
each mutant were plaque-purified from the primary
stocks of SFV4mut3A, SFV4D3 and SFV4D7, and their
Fig. 2. Growth curves of SFV4 (.), SFV4mut3A (m), SFV4D3
(&) and SFV4D7(X)i n8 10
6 BHK-21 cells upon (a) transfection
with 50 mg in vitro-synthesized RNAs or (b) infection at an m.o.i. of
10. Data from one of two reproducible experiments are shown.
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revealed three single mutations (P181Q, L234F and
Q357L) and two double mutations (M124V+A197D and
DG224+T352S) in the SFV4mut3A and SFV4D3 clones,
respectively (Table 1). All of these mutations, except
DG224, were single-nucleotide replacements and localized
either in the methyltransferase/guanylyltransferase (MT/
GT) domain (M124V, P181Q, L234F, A197D and DG224)
or in the C-terminal region (T352S and Q357L) of nsP1. In
contrast to SFV4mut3A and SFV4D3, no mutations were
found in the non-structural region of any plaque-purified
isolate originating from SFV4D7.
Identified mutations rescue the infectivity of
SFV4mut3A and SFV4D3
The identified mutations were introduced into SFV4mut3A
(P181Q, L234F and Q357L) or SFV4D3 (M124V+A197D
and DG224+T352S) and their effects were analysed as for
the original mutants. It was found that the introduction of
these mutations increased the infectivity of in vitro-
synthesized RNAs to a level comparable with that of
SFV4 RNA (Table 1). Thus, the identified mutations did
rescue the infectivity of SFV harbouring mut3A or D3
mutations.
Changes identified in SFV4D3 isolates were double
mutations (M124V+A197D and DG224+T352S). When
they were introduced separately into pSFV4D3, the
subsequent analysis revealed that only one mutation from
each pair (A197D and DG224, respectively) provided a
compensatory effect, whereas the other was functionally
neutral (Table 1).
In order to demonstrate that compensatory mutations are
also responsible for the differences between primary and
secondary growth curves (Fig. 2), similar growth curves for
two recombinants, SFV4mut3A-P181Q and SFV4D3-
DG224+T352S, were constructed. It was found that, unlike
SFV4mut3A and SFV4D3, the growth of SFV4mut3A-P181Q
and SFV4D3-DG224+T352S in transfected BHK-21 cells
had no delay in virion release, although their accumulation
was slightly slower than that of SFV4 (Fig. 3a). When BHK-
21 cells were infected with the primary viral stocks of
SFV4mut3A-P181Q and SFV4D3-DG224+T352S, no differ-
ences from SFV4 were detected (Fig. 3b).
Effects of compensatory mutations in SFV4
The compensatory mutations were introduced into SFV4
and their effects were analysed as described above. The only
change detected in this experiment was a slight decrease in
the infectivity of transcripts harbouring these mutations
(Table 2). Thus, the identified compensatory mutations are
almost-neutral mutations in the SFV4 background.
Next, the question of whether the compensatory mutations
were effective only in their original background was
examined. For that purpose, mutation L234F was intro-
duced into genomes harbouring D3o rD7 deletions and
analysed as described above. The results indicated that the
L234F was able to compensate defects caused by the D3
Table 1. Localization of compensatory mutations and their
effect on the infectivity of SFV genomes with the mut3A or D3
mutations
Original mutation
in nsP1
Compensatory
mutation found
Infectivity of
full-length RNA
(p.f.u. mg
”1)*
None – 9610
5
CCCAAAA (418–420) P181Q 6610
5
CCCAAAA (418–420) L234F 1610
5
CCCAAAA (418–420) Q357L 6610
5
DCCC (418–420) M124V+A197D 3610
5
M124V ,10
A197D 1610
5
DCCC (418–420) DG224+T352S 9610
5
DG224 6610
5
T352S ,10
*Infectivity of full-length SFV genomes was measured by infectious
centre assay. The numbers shown represent data from one of two
experiments with similar results.
Fig. 3. Growth curves of SFV4 (.), SFV4mut3A-P181Q (m) and
SFV4D3-DG224+T352S (&) in BHK-21 cells upon (a) transfec-
tion with 50 mg in vitro-synthesized RNAs or (b) infection with
primary stock virus at an m.o.i. of 10. Data from one of two
reproducible experiments are shown.
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decreased the infectivity of full-length RNA of SFV4D7b y
approximately 20-fold (Table 2). Based on these results, it
can be suggested that the consequences of mut3A and D3
have a rather similar effect on nsP1 and can therefore be
compensated by the same mutation(s). In contrast, the D7
mutation has a different effect.
Enzymic activities and palmitoylation of mutant
forms of nsP1
It has been reported that the CCC to AAA (418–420)
mutation has a relatively minor effect on the enzymic
activities of recombinant nsP1 (Laakkonen et al., 1996). To
find out whether that is the case for nsP1s harbouring
mut3A, D3 and D7 mutations or compensatory mutations
together with mut3A and D3 mutations, proteins were
expressed in E. coli and their GT activities were assayed. As
is evident from the data presented in Fig. 4(a), the GT
activity of recombinant proteins with mut3A, D3 and D7
was very similar to that of wt nsP1 and all recombinant
proteins with compensatory mutations had GT activity as
well. As the GT activity of nsP1 is completely dependent on
its MT activity (Ahola & Kaariainen, 1995), the data
indicate that the analysed proteins should possess MT
activity as well. Thus, it can be concluded that defects (if
any) in enzymic activities of mutant nsP1s could not
represent the main reason for the very low infectivity of
mut3A and D3 constructs.
As the enzymic activities of nsP1 are strictly dependent on
its association with membranes (Ahola et al., 1999), the
data presented above clearly indicate that all recombinant
nsP1s must be membrane-bound. This finding is consistent
with the model that the primary binding of nsP1 to the
membranes is mediated by the BP and that only then is it
strengthened by covalent palmitoylation (Spuul et al.,
2007). All three mutations analysed in this study were
expected to abolish palmitoylation of nsP1. The reversion
of original mutations was never observed in this study,
indicating strongly that palmitoylation of nsP1 was not
restored. This hypothesis was verified directly by expres-
sion of mutant nsP1s by use of the MVA-T7 system in
HeLa cells and the labelling of recombinant proteins with
[9,10(n)-
3H]palmitic acid. This experiment revealed that
only wt nsP1 was palmitoylated (Fig. 4b), confirming that
mut3A, D3 and D7 did indeed abolish palmitoylation and
that the compensatory mutations did not restore that
function.
Subcellular localization of mutant forms of nsP1
The analysis of the subcellular localization of mutant nsP1s
in transfected HeLa cells by the MVA-T7 system revealed
that, as expected, the wt nsP1 was localized almost
exclusively at the plasma membrane and caused extensive
induction of filopodium-like extensions (Fig. 5a). In
contrast, nsP1-mut3A and nsP1-D3 localized both on the
plasma membrane and in the cytoplasm of transfected cells
and caused no (or very little) formation of filopodium-like
extensions (Fig. 5b, c). Expression of nsP1-D7 also did not
result in formation of filopodium-like extensions but, in
contrast to nsP1-mut3 and nsP1-D3, the nsP1-D7 localized
Table 2. Effects of compensatory mutations on the infectivity
of SFV4 genome
Alteration in the
palmitoylation
site of nsP1
Compensatory
mutation
introduced
Full-length RNA
infectivity
(p.f.u. mg
”1)*
None None 9.0610
5
None P181Q 7.8610
5
None L234F 1.3610
6
None Q357L 1.2610
6
None M124V+A197D 4.4610
5
None DG224+T352S 2.0610
5
DCCC (418–420) L234F 5.7610
5
D RSLTCCC (414–420) L234F 1.0610
3
*Infectivity of full-length SFV genomes was measured by infectious
centre assay. The numbers shown represent data from one of two
experiments with similar results.
Fig. 4. Guanylyltransferase activity and palmitoylation of wt and
mutant nsP1 proteins. (a) Guanylyltransferase activity of recombi-
nant nsP1s. Western blots of the S15 fractions of bacterial
extracts were probed with anti-nsP1 antiserum. The same extracts
were incubated with [a-
32P]GTP in the presence of 100 mM
AdoMet, and analysed by SDS-PAGE and autoradiography to
reveal the covalent guanylate complexes. (b) Palmitoylation of
transiently expressed nsP1s. HeLa cells were infected with MVA-
T7, transfected with the respective pTSF1 constructs and labelled
with [
3H]palmitate. Western blots of HeLa extracts were probed
with anti-nsP1 antiserum. Equal amounts of the same extracts
were immunoprecipitated with anti-nsP1, separated by SDS-
PAGE and autoradiographed to reveal the [
3H]palmitate labelling
of nsP1 variants.
E. Z ˇusinaite and others
1982 Journal of General Virology 88mostly at the plasma membrane of transfected cells
(Fig. 5d). Addition of the compensatory mutations to
nsP1-mut3 and nsP1-D3 always resulted in more extensive
plasma-membrane localization of the recombinant pro-
teins (Fig. 5e–i); this phenomenon is clearest in the
cases of nsP1-mut3A-Q357L (Fig. 5g) and nsP1-D3-
M124V+A197D (Fig. 5h). With the notable exception of
nsP1-mut3A-L234F (Fig. 5f), all of the recombinant
proteins with compensatory mutations also induced the
formation of filopodium-like extensions, although these
structures were always less prominent than those induced
by wt nsP1. Thus, the effects of compensatory mutations
on the formation of filopodium-like extensions differ from
each other. However, it should be noted that all viruses
with compensatory mutations in their genome (but not
SFV4-D7) caused the formation of filopodium-like exten-
sions on the plasma membrane of infected BHK-21 cells,
indicating that this phenomenon may depend on the mode
of nsP1 expression and/or on the host cell type.
Mutations at the palmitoylation site of nsP1 affect
its interaction with nsP4
It has been reported that nsP1 interacts directly at least
with nsP3 and nsP4, and that these interactions can be
detected even if these proteins are expressed pairwise in a
transient system (Salonen et al., 2003). To determine the
effects of mut3A, D3 and D7 on interactions of nsP1 with
other non-structural proteins, nsP1, nsP1-mut3A, nsP1-D3
and nsP1-D7 were expressed pairwise with nsP2, nsP3 or
nsP4 in Cos-7 cells and complexes were immunoprecipi-
tated under native conditions with the anti-nsP1 antibody.
The results of this experiment failed to reveal any difference
between wt and mutated nsP1 regarding their interactions
with nsP2 and nsP3, which were negative and positive,
respectively (data not shown). However, in contrast to wt
nsP1 and nsP1-D7, nsP1-mut3A and nsP1-D3 failed to
interact with nsP4 (Fig. 6). Importantly, it was also
demonstrated that the introduction of the compensatory
mutations P181Q, L234F or Q357L into nsP1-mut3A and
mutations M124V+A197D or DG224+T352S into nsP1-
D3 restored their interaction with nsP4 (Fig. 6). These
findings suggest the possibility that one of the reasons for
the low infectivity of SFV4mut3A and SFV4D3 was the lack
or significant debilitation of interaction between nsP1 and
nsP4 and that the compensation occurred through its
restoration.
DISCUSSION
Cysteines at positions 418–420 are critical for the
palmitoylation of SFV nsP1 (Laakkonen et al., 1996). In
this work, we have shown that the replacement of these
cysteines by alanines or their deletion was detrimental to
recombinant RNA infectivity, whilst the more extended
deletion comprising residues 414–420 caused a less dramatic
effect. It appeared that the accumulation of SFV4mut3A and
SFV4D3 to high titres in the second-passage virus stock was
Fig. 5. Subcellular localization and membrane
binding of wild-type and mutant nsP1 proteins.
HeLa cells infected with MVA-T7 were trans-
fected with plasmid encoding the indicated
nsP1 variants. The cells were fixed and stained
with Alexa488-conjugated concanavalin A
(conA; green) to visualize the plasma mem-
brane, and then permeabilized for Alexa568–
anti-nsP1 staining (red). Co-localization of
conA and nsP1 is seen in yellow. The arrow
in (a) indicates filopodium-like structures.
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in the MT/GT domain or in the C-terminal part of nsP1.
None of the compensatory mutations found in this study
restored the palmitoylation of recombinant proteins,
confirming that the palmitoylation of nsP1 is not strictly
required for SFV replication (Ahola et al., 2000). The
discrepancy between the results described above and those
reported previously is likely to be due to the hetero-
geneous nature of the mutant virus stock used in the
earlier study.
The rapid accumulation of compensatory mutations
requires very low initial infectivity of the original mutant
RNA. In this case, the infection will start from a small
fraction of transfected cells, followed by the release of virus
and de novo infection of initially uninfected cells, thus
providing conditions for the selection of mutations with a
positive impact on virus growth. No compensatory
mutation in the non-structural region of plaque-purified
isolates of SFV4D7 was identified in this study; the
sufficiently high infectivity of SFV4D7 prevented the
takeover of the original genotype by pseudo-revertants
during single-cycle infection. The change of the single
cysteine to alanine at the palmitoylation site of SIN nsP1
had only a very mild effect on virus multiplication in
transfected cells. The changes were even smaller than those
observed for SFV4D7 and, therefore, as for SFV4D7, no
compensatory changes are required for SIN1PA2.I ti s
tempting to speculate that the mild effect in the case of SIN
may be due to the smaller change in the protein (only one
cysteine residue is mutated); however, the results obtained
for SFV4D7 indicate that there is no direct correlation
between the size of the mutated region and the corre-
sponding phenotypic change.
It is evident from our data that the lack of nsP1
palmitoylation is not the main reason for the low
infectivity of SFV4mut3A and SFV4D3. Similarly, this
defect cannot be attributed to defects in GT/MT activities,
as the corresponding recombinant proteins were enzymi-
cally active. In addition, although most of the identified
compensatory mutations were located within the MT/GT
domain of nsP1, none of them caused a significant increase
in enzymic activity of the corresponding recombinant
protein (Fig. 4a).
Direct interactions of nsP1 with nsP3 and nsP4 have been
shown previously in co-immunoprecipitation experiments
(Salonen et al., 2003). The importance of interactions
between nsP1 and the N terminus of nsP4 for the
recognition of the promoter for minus-strand RNA
synthesis has been revealed in SIN replication (Shirako
et al., 2000). Another genetic study also supported nsP1–
nsP4 interaction (Fata et al., 2002). Here, we demonstrated
that mutations mut3A and D3 destroyed or debilitated the
interaction between nsP1 and nsP4, possibly resulting in
defect(s) in the assembly of the replication complex.
Interestingly, the D7 mutation did not preclude the
interaction of nsP1 with nsP4. A possible explanation
could be that the conformational changes in the nsP1
three-dimensional structure, caused on the one hand by
mut3A or D3 mutations and on the other hand by D7
mutation, are different. This conclusion is supported by the
finding that compensatory mutation L234F, identified
from an SFV4mut3A isolate, could compensate D3, but
was deleterious for D7.
The presence of enzymic activity and plasma-membrane
localization indicate that the lack of palmitoylation does
not prevent the membrane binding of the corresponding
mutant nsP1s. However, some changes in subcellular
localization of nsP1 were observed for both nsP1-mut3A
and nsP1-D3: they are less abundant at the plasma
membrane and partially localized in the cytoplasm of
transfected cells. As the third mutant protein, nsP1-D7, as
well as proteins with compensatory mutations, had more
extensive plasma-membrane localization (Fig. 5), it can be
speculated that the defect in membrane association and/or
subcellular targeting may be another mechanism under-
lying the low infectivity of these recombinant viruses.
Indeed, if mut3A and D3 were to result only in defects in
the interaction between nsP1 and nsP4, it would be logical
to assume that compensatory mutations could take place in
either of the proteins. However, we were unable to find any
mutations in the nsP4 region either in the plaque-purified
viruses described above or in a larger number of isolates,
purified and analysed specifically for this purpose (data not
shown). The most likely explanation for this is that mut3A
or D3 led to multiple defects in the localization and
functions of nsP1 and only changes in the same protein can
compensate for these defects.
Mutations preventing the palmitoylation of nsP1 are
reported to prevent the formation of filopodium-like
Fig. 6. Interaction of wt and mutant forms of nsP1 with nsP4. Cos-
7 cells were pairwise transfected with pCG plasmids expressing
nsP4 and wt or mutated nsP1. Cells were collected 48 h post-
transfection, lysed and proteins were precipitated with nsP1-
specific antibody. The immunoprecipitated fraction was analysed
by SDS-PAGE, and the presence or absence of co-immunopreci-
pitated nsP4 (with N-terminal 3F12 tag) was revealed by Western
blotting by the use of 3F12 tag-specific mouse monoclonal
antibody. Western blots of 10 mg total lysate of cotransfected
Cos-7 cells were probed with anti-nsP1 antiserum. ” and +
represent 10 mg total protein of mock-transfected Cos-7 cells and
Cos-7 cells transfected with pCG3F12-nsP4, respectively.
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2000; Laakkonen et al., 1998). The biological significance of
filopodium formation is not known but, nevertheless, it
represents a notable characteristic of SFV infection.
Therefore, it is interesting to note that HeLa cells transiently
expressing nsP1-mut3A-P181Q, nsP1-mut3A-Q357L, nsP1-
D3-M124V+A197D and nsP1-D3-DG224+T352S did have
filopodium-like extensions on the plasma membrane,
indicating that nsP1 palmitoylation is not strictly required
for the formation of these structures. In contrast to other
compensatory mutations, the L234F change did not restore
the formation of filopodium-like extensions; therefore, it is
possible that these mutants can be used for studies of the
functional significance of this poorly understood phenom-
enon.However,itshouldbementionedthat,inBHK-21cells
infected with the corresponding viruses, the morpholo-
gical differences were much less prominent, indicating
possible significance of the expression mode (infection
versus transient expression), presence or absence of other
non-structural proteins and/or host cell type for this
phenomenon.
Taken together, our results support the idea that
palmitoylation of nsP1 as such is not required for efficient
replication, nor does it determine the interaction between
nsP1 and nsP4 or the initial plasma-membrane localization
of nsP1. Instead, it is more likely that the effects of
mutations can be attributed to conformational changes
caused by the deletions/substitutions at the palmitoylation
site.
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